The reaction of NaI with 2 equiv of HC(pz)
3 or HC(3,5-Me
2pz)
3 (pz = pyrazolyl ring) leads to the formation of{[HC(pz)
3]
2Na}(I) (
1) and {[HC(3,5-Me
2pz)
3]
2Na}(I) (
2), respectively. Both compounds have trigonally distortedoctahedral arrangements about the sodium. A similar reaction of KPF
6 with HC(3,5-Me
2pz)
3 results in the formationof {[HC(3,5-Me
2pz)
3]
2K}(PF
6) (
3), a complex also shown crystallographically to have a trigonally distorted octahedralarrangement about the potassium, which is an unusually low coordination number for this large metal ion. Thecomplex {[HC(pz)
3]
2Sr}(BF
4)
2 (
4) forms in the reaction of Sr(acac)
2 (acac = acetylacetonate) with HBF
4·Et
2Ofollowed by 2 equiv of HC(pz)
3. The structure is highly distorted, showing
3 bonding of both tris(pyrazolyl)methaneligands and, in addition, interactions with the metal from three fluorine atoms from the BF
4- counterions. Thesymmetrical structure of
1 and the nine-coordinate structure of
4 are both very different from the distorted, six-coordinate structure {[HC(pz)
3]
2Pb}(BF
4)
2, indicating that for this compound the lone pair on lead(II) is influencingthe structure. The reaction of M(acac)
2 (M = Sr, Ca) with H{B[3,5-(CF
3)
2C
6H
3]
4} followed by 2 equiv of HC(pz)
3produces {[HC(pz)
3]
2(Hacac)Sr}{B[3,5-(CF
3)
2C
6H
3]
4}
2 (
5) (when the reaction is done in CH
2Cl
2), {[HC(pz)
3]
2(Me
2CO)
2Sr}{B[3,5-(CF
3)
2C
6H
3]
4}
2 (
6) (when the reaction is done in acetone)
, and {[HC(pz)
3]
2(Hacac)Ca}{B[3,5-(CF
3)
2C
6H
3]
4}
2 (
7), respectively. The structures of all three complexes show a distorted eight-coordinate arrangementof the ligands about the metal. Crystal data:
1 is orthorhombic,
Pnma,
a = 16.931(1),
b = 22.368(3),
c = 7.937(2) Å,
= 90,
= 90,
= 90
, Z = 4;
2 is trigonal,
R,
a = 10.
7483(8),
b = 10.
7483(8),
c = 35.395(4) Å,
= 90,
= 90,
= 120
, Z = 3;
3 is monoclinic,
P2
1/c,
a = 9.144(4),
b = 13.377(6),
c = 15.988(7) Å,
=90,
= 92.291(10),
= 90
, Z = 2;
4 is hexagonal,
P6
5,
a = 9.42530(10),
b = 9.42530(10),
c = 55.3713(5)Å,
= 90,
= 90,
= 120
, Z = 6;
5 is monoclinic,
P2
/n,
a = 14.1601(3),
b = 13.1756(3),
c = 27.1826(6)Å,
= 90,
= 90.1
744(7),
= 90
, Z = 2;
6 is monoclinic,
P2
/n,
a = 14.2709(7),
b = 13.2646(7),
c =27.4189(13) Å,
= 90,
= 90.3850(10),
= 90
, Z = 2;
7 is monoclinic,
P2
/n,
a = 14.2388(2),
b = 13.1919(2),
c = 26.7879(3) Å,
= 90,
= 90.0650(8),
= 90
, Z = 2.